The company is scaling up manufacturing and commercial activities as it prepares to enter the U.S. market via the Food and Drug Administration’s de novo pathway.

Add Yahoo as a preferred source to see more of our stories on Google. Getty Images; Alyssa Powell/BI Needle-free devices like TAP and Tasso offer painless blood collection, a benefit for the squeamish ...

Vitestro secures $70M Series B funding to expand its autonomous robotic blood collection technology and global healthcare adoption.

Vitestro's ARPD blood-drawing robot gained an EU CE mark in 2024 and launched in the healthcare settings across the region in ...

BD received its FDA authorizations for two blood draw devices that are part of the new BD MiniDraw Capillary Blood Collection System at the end of 2023. The devices, as the name implies, collect blood ...

Chicago (tca/dpa) — The practice of drawing blood has changed very little over the decades. It looks about the same now as it did 50 years ago. That process, however, may be about to get a modern ...

SEATTLE--(BUSINESS WIRE)--Tasso, Inc., the leading provider of patient-centric, clinical grade blood collection solutions, surveyed more than 600 adults (age 18-65+) within the United States to assess ...

Modern blood testing is the foundation of clinical screening and decision-making. Timely disease diagnosis, prevention and chronic care management depend on accurate diagnostic testing. More than 7 ...

Dr. Zev Williams, the chief of reproductive endocrinology and infertility at Columbia University Irving Medical Center, clearly remembers a particular patient who walked into his clinic. She was only ...